癌症免疫学研究的生物标志物和实验模型
Hengyi Xu1,2, Ziqi Jia3, Fengshuo Liu2
1State Key Laboratory of Molecular Oncology National Cancer Center /National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
MedComm
|December 4, 2023
概括
瘤免疫疗法的进步需要更好的癌症研究工具. 本综述涵盖了关键的生物标志物和实验模型,如3D培养和动物模型,对于预测治疗成功和了解瘤微环境至关重要.
科学领域:
- 癌症免疫学 癌症免疫学
- 免疫疗法研究研究
- 发现生物标志物的发现.
背景情况:
- 瘤免疫疗法正在迅速发展,需要改进的研究工具.
- 目前的生物标志物 (PD-L1,MSI,TILs,ctDNA) 和实验模型对于癌症免疫学至关重要.
- 需要可复制的模型来研究瘤-免疫相互作用和免疫疗法的疗效.
研究的目的:
- 提供癌症免疫学当前生物标志物和实验模型的全面概述.
- 分析这些工具的优势,局限性和前景.
- 突出它们在预测免疫治疗结果和复制瘤微环境中的作用.
主要方法:
- 对癌症免疫学生物标志物和实验模型的现有文献的审查.
- 分析各种体外 (3D培养,生物打印) 和体内 (动物模型,人性化模型) 系统.
- 专注于生物标志物的应用,以预测免疫疗法反应.
主要成果:
- 生物标记物包括表面蛋白 (PD-L1),遗传特征 (MSI),瘤透淋巴细胞和液体活检标记物 (ctDNA).
- 实验模型范围从3D体外培养到先进的动物模型,复制瘤微环境.
- 这些模型对于研究瘤-免疫相互作用和评估免疫疗法的疗效至关重要.
结论:
- 整合先进的生物标志物和实验模型是推动癌症免疫学研究的关键.
- 有效的生物标志物和模型对于预测免疫治疗结果至关重要.
- 本综述是癌症免疫学研究最前沿的资源.
相关概念视频
02:43Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529